S

SMAIO SA
PAR:ALSMA

Watchlist Manager
SMAIO SA
PAR:ALSMA
Watchlist
Price: 7.15 EUR -1.38%
Market Cap: €44m

Multiples-Based Value

The Multiples-Based Value of one ALSMA stock under the Base Case scenario is 4.47 EUR. Compared to the current market price of 7.15 EUR, SMAIO SA is Overvalued by 37%.

Multiples-Based Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

ALSMA Multiples-Based Value
Base Case
4.47 EUR
Overvaluation 37%
Multiples-Based Value
Price €7.15
S
Worst Case
Base Case
Best Case

Multiples Across Competitors

ALSMA Competitors Multiples
SMAIO SA Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
FR
SMAIO SA
PAR:ALSMA
40.3m EUR 4.9 -21.8 -34.4 -17.1
US
Abbott Laboratories
NYSE:ABT
177.8B USD 4 27.3 15.6 21.5
US
Intuitive Surgical Inc
NASDAQ:ISRG
164.9B USD 16.4 57.7 43.7 53.8
US
Stryker Corp
NYSE:SYK
126B USD 5 38.8 19.9 24
IE
Medtronic PLC
NYSE:MDT
110.4B USD 3.1 23.9 13.3 19.3
US
Boston Scientific Corp
NYSE:BSX
91.9B USD 4.6 31.7 18.8 25.3
DE
Siemens Healthineers AG
XETRA:SHL
41B EUR 1.7 19.2 10.8 15.3
US
Edwards Lifesciences Corp
NYSE:EW
47.2B USD 7.8 44 24.2 26.5
US
IDEXX Laboratories Inc
NASDAQ:IDXX
45B USD 10.5 42.5 30.1 33.3
US
Becton Dickinson and Co
NYSE:BDX
44.5B USD 2 25.3 10 16.9
US
Resmed Inc
NYSE:RMD
32.5B USD 6 21.8 15.3 17
EV/EBITDA Multiple
EBITDA Growth EV/EBITDA to Growth
FR
S
SMAIO SA
PAR:ALSMA
Average EV/EBITDA: 20.2
Negative Multiple: -34.4
N/A N/A
US
Abbott Laboratories
NYSE:ABT
15.6
11%
1.4
US
Intuitive Surgical Inc
NASDAQ:ISRG
43.7
23%
1.9
US
Stryker Corp
NYSE:SYK
19.9
12%
1.7
IE
Medtronic PLC
NYSE:MDT
13.3
8%
1.7
US
Boston Scientific Corp
NYSE:BSX
18.8
18%
1
DE
Siemens Healthineers AG
XETRA:SHL
10.8
10%
1.1
US
Edwards Lifesciences Corp
NYSE:EW
24.2
14%
1.7
US
IDEXX Laboratories Inc
NASDAQ:IDXX
30.1
11%
2.7
US
Becton Dickinson and Co
NYSE:BDX
10
1%
10
US
Resmed Inc
NYSE:RMD
15.3
11%
1.4
EV/EBIT Multiple
EBIT Growth EV/EBIT to Growth
FR
S
SMAIO SA
PAR:ALSMA
Average EV/EBIT: 25.3
Negative Multiple: -17.1
N/A N/A
US
Abbott Laboratories
NYSE:ABT
21.5
18%
1.2
US
Intuitive Surgical Inc
NASDAQ:ISRG
53.8
25%
2.2
US
Stryker Corp
NYSE:SYK
24
16%
1.5
IE
Medtronic PLC
NYSE:MDT
19.3
17%
1.1
US
Boston Scientific Corp
NYSE:BSX
25.3
25%
1
DE
Siemens Healthineers AG
XETRA:SHL
15.3
15%
1
US
Edwards Lifesciences Corp
NYSE:EW
26.5
15%
1.8
US
IDEXX Laboratories Inc
NASDAQ:IDXX
33.3
12%
2.8
US
Becton Dickinson and Co
NYSE:BDX
16.9
15%
1.1
US
Resmed Inc
NYSE:RMD
17
12%
1.4
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett